Exploring and exploiting plant cyclic peptides for drug discovery and development

Area of Science:

• Biochemistry
• Pharmacology
• Drug Discovery

Background:

• Natural peptides, like insulin, are crucial for therapeutic development, with many approved drugs originating from microorganisms and animals.
• Plant cyclic peptides, characterized by rigid structures, good bioavailability, and membrane permeability, represent a largely unexplored resource for drug development.

Purpose of the Study:

• To review the three major classes of plant cyclic peptides.
• To summarize their potential medical applications.
• To discuss leveraging plant genome information and biosynthetic pathways for novel peptide discovery and development.

Main Methods:

• Review of existing literature on plant cyclic peptides.
• Analysis of genome information for identifying new cyclic peptides.
• Examination of biosynthetic pathways for production and drug development insights.

Main Results:

• Identification of three major classes of plant cyclic peptides.
• Summary of their diverse potential medical applications.
• Discussion of methods for accelerating discovery and development using genomic and biosynthetic data.

Conclusions:

• Plant cyclic peptides hold significant, largely unexplored therapeutic potential.
• Genomic and biosynthetic insights offer new avenues for drug discovery and development.
• The future is promising for plant-derived peptide drugs.